Atherogenic index and coronarian risk – comparative assessment regarding the particularities of chronic autoimmune thyroiditis presence

1. Ichiki, T. (2010). Thyroid hormone and atherosclerosis. Vascul Pharmacol, 52(3-4), 151-156. doi: 10.1016/j.vph.2009.09.00410.1016/j.vph.2009.09.004Search in Google Scholar

2. Singh, S., Duggal, J., Molnar, J., Maldonado, F., Barsano, C. P., & Arora, R. (2008). Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol, 125(1), 41-48. doi: 10.1016/j.ijcard.2007.02.02710.1016/j.ijcard.2007.02.027Search in Google Scholar

3. Ciccone, M.M., De Pergola, G., Porcelli, M. T., Scicchitano, P., Caldarola, P., Iacoviello, M. & Favale, S. (2010). Increased carotid IMT in overweight and obese women affected by Hashimoto’s thyroiditis: an adiposity and autoimmune linkage? BMC Cardiovasc Disord, 10, 22. doi: 10.1186/1471-2261-10-2210.1186/1471-2261-10-22Search in Google Scholar

4. Toruner, F., Altinova, A. E., Karakoc, A., Yetkin, I., Ayvaz, G., Cakir, N. & Arslan, M. (2008). Risk factors for cardiovascular disease in patients with subclinical hypothyroidism. Adv Ther, 25(5), 430-437. doi: 10.1007/s12325-008-0053-710.1007/s12325-008-0053-7Search in Google Scholar

5. Valentina, V. N., Marijan, B., Chedo, D. & Branka, K. (2011). Subclinical hypothyroidism and risk to carotid atherosclerosis. Arq Bras Endocrinol Metabol, 55(7), 475-480.10.1590/S0004-27302011000700007Search in Google Scholar

6. Palmieri, E. A., Fazio, S., Lombardi, G. & Biondi, B. (2004). Subclinical hypothyroidism and cardiovascular risk: a reason to treat? Treat Endocrinol, 3(4), 233-244.10.2165/00024677-200403040-00005Search in Google Scholar

7. Thvilum, M., Brandt, F., Brix, T. H. & Hegedus, L. (2012). A review of the evidence for and against increased mortality in hypothyroidism. Nat Rev Endocrinol, 8(7), 417-424. doi: 10.1038/ nrendo.2012.29 10.1038/nrendo.2012.29Search in Google Scholar